<DOC>
	<DOCNO>NCT00874029</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness radiofrequency ablation ( RFA ) use Halt System treatment patient symptomatic uterine fibroid .</brief_summary>
	<brief_title>Laparoscopic Radiofrequency Ablation ( RFA ) Symptomatic Uterine Fibroids</brief_title>
	<detailed_description>In single-arm study , subject symptomatic uterine fibroid laparoscopic surgery intra-abdominal ultrasound guide RF ablation uterine fibroid use Halt System .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Are premenopausal ≥ 25 year old Have symptomatic uterine fibroid Have uterine gestational size ≤14 week determine pelvic exam Have ≤ 6 ( six ) treatable fibroid single fibroid exceed 7 cm diameter measure ultrasound magnetic resonance imaging ( MRI ) . Only Fibroids great 1cm diameter treat study Have total uterine fibroid volume exceed 300cc ultrasound contrastenhanced MRI evaluation Have clinical menorrhagia indicate menstrual blood loss ≥160 mL 500 ml one baseline cycle two baseline cycle within three month prior treatment Have history least 3 month menorrhagia within last six month Desire uterine preservation Do desire current future childbearing Have normal coagulation profile international normalized ratio ( INR ) , Platelets , Prothrombin Time , Partial Thromboplastin Time ( PTT ) Have normal Pap smear within past 12 month Are practice nonhormonal stable hormonal contraception If woman currently take hormonal contraceptive , hormonal contraceptive minimum three month prior study enrollment , agree continue without change regimen 12 month followup OR If woman currently take hormonal contraceptive , take hormonal contraceptive minimum three month prior study enrollment , agree continue without change regimen 12 month follow . ** **Note : Hormonal contraceptive use must terminate 30 day prior treatment resume postoperatively within 60 day post treatment instructed Investigator . Are willing able comply study test , procedure , assessment tool Are willing able return require follow visit follow study enrollment Must pas preoperative health exam ( ASA IIII ) Are capable provide informed consent Have contraindication laparoscopic surgery and/or general anesthesia . ( Contraindications include anemia , define hemoglobin level 10 hematocrit level less 30 . ) Have prior pelvic surgery ( exception Csection , tubal ligation , diagnostic laparoscopy ) , know significant intraabdominal adhesion ( defined adhesion would require extensive dissection mobilize view surface uterus ) Have previously undergone endometrial ablation , uterine artery embolization , uterine artery ligation , uterinepreserving technique reduction menstrual bleeding ( exception hysteroscopic myomectomy &gt; 1 year ago ) Patients require elective concomitant procedure Have contraindication magnetic resonance imaging ( MRI ) Desire current future childbearing Are pregnant lactate Have take Gonadotropinreleasing hormone ( GnRh ) agonist within three month prior screen procedure Have implant intrauterine fallopian tube device contraception remove one month prior treatment Have dysfunctional uterine bleed bleed period Have chronic pelvic pain due uterine fibroid Have know suspect endometriosis Have know suspect adenomyosis base Ultrasound MRI finding Have active history pelvic inflammatory disease Have history evidence gynecologic malignancy premalignancy within past five year Have pelvic radiation Have nonuterine pelvic mass Have cervical myoma Have one pedunculated subserosal fibroid `` type zero '' ( completely intracavitary ) submucous fibroid Are perimenopausal ( defined woman 40 year age old Follicular Stimulating Hormone level ≥ 25 International Units ( IU ) menopausal Are unable give inform consent In medical judgment investigator participate study</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Uterine Fibroids</keyword>
	<keyword>Myomas</keyword>
</DOC>